Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study)
Condition(s):Renal Cancer CellLast Updated:March 7, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Renal Cancer CellLast Updated:March 7, 2018Terminated
Condition(s):Renal Cell Carcinoma; Renal Cancer; Renal Cancer MetastaticLast Updated:April 19, 2023Recruiting
Condition(s):Renal Cell Carcinoma; Metastatic Kidney CancerLast Updated:April 5, 2021Withdrawn
Condition(s):Health Services ResearchLast Updated:July 26, 2017Completed
Condition(s):Gastrointestinal Stromal TumorsLast Updated:May 10, 2017Completed
Condition(s):Advanced/ Metastatic Renal Cell CancerLast Updated:December 21, 2020Completed
Condition(s):Carcinoma, Renal CellLast Updated:March 17, 2016Completed
Condition(s):Metastatic Renal Cell CancerLast Updated:June 30, 2020Terminated
Condition(s):Clear Cell Metastatic Renal Cell CarcinomaLast Updated:March 23, 2021Completed
Condition(s):Kidney NeoplasmsLast Updated:May 6, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.